Brian Caveney

Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer · Labcorp Holdings

Clinical Laboratory and Drug Development Services

Brian Caveney is Executive Vice President and President of Biopharma Laboratory Services and Chief Medical and Scientific Officer at Labcorp. A physician and attorney, he previously held clinical leadership roles at Blue Cross NC and Duke.

Last reviewed: Oct 30, 2026

Brian Caveney

Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Labcorp Holdings

Last Reviewed: October 30, 2026

Executive Summary

Brian Caveney is Executive Vice President and President of Biopharma Laboratory Services and Chief Medical and Scientific Officer at Labcorp. A physician and attorney, he previously held clinical leadership roles at Blue Cross NC and Duke.

Career Highlights

  • Worked as a physician and assistant professor at Duke before joining Blue Cross NC in 2011.
  • Became Labcorp chief medical officer in September 2017.
  • Led Diagnostics from 2019 to 2023 and early development laboratories from 2023 to 2026.
  • Added the combined biopharma laboratory services remit in September 2026.

Professional Journey

Caveney practiced medicine and served as an assistant professor at Duke University Medical Center before joining Blue Cross and Blue Shield of North Carolina in 2011. At the insurer, he became chief medical officer and also served as chief clinical officer of Mosaic Health Solutions, its diversified health solutions subsidiary.

He joined Labcorp in September 2017 as senior vice president and chief medical officer. In November 2019, he became executive vice president and president of Diagnostics while continuing as chief medical officer.

In May 2023, Caveney moved into leadership of Early Development Research Laboratories and became chief medical and scientific officer. The assignment extended his operating leadership from diagnostic services into the research laboratory business.

Effective September 1, 2026, he became president of Biopharma Laboratory Services, combining responsibility for early development research and central laboratories. He retained the chief medical and scientific officer responsibilities alongside the expanded business role.

Education

Caveney earned his M.D. and J.D. from West Virginia University and a Master of Public Health in Health Policy and Administration from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center.